Featured 13F manager
Ratan Capital Management LP Nehal Chopra
Miami, FL 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $310M
- 48 Positions
- 2026 Q2
- +15.2% QoQ
- Top 5 42.2%
Nehal Chopra files Ratan Capital Management LP as a Form 13F. The latest book is 2026 Q2 at $310M, up 15.2% QoQ, led by Silicon Motion Technology, Intel, and VST.
Portfolio
top 5 42.2% · top 10 67.9%
- SIMO - Silicon Motion Technology 12.7%
- INTC - Intel 8.3%
- VST — 7.4%
- AMZN - Amazon 7.3%
- QCOM - Qualcomm 6.5%
- FRMI - Fermi 6.4%
- BE - Bloom Energy · CL A 5.1%
- ARM — 5.0%
- MU - Micron Technology 4.8%
- MaxLinear 4.4%
- AMD - Advanced Micro Devices 4.4%
- LION - Lionsgate Studios 3.6%
- Other 24.1%
AUM over time
Book
| NVDA - NVIDIA | 16.68% | Add +2546.0% | 446,110 | $123.54 | $55M | +429,250 | +$40M |
| VRT - Vertiv | 14.79% | Add +24.4% | 564,518 | $86.57 | $49M | +110,739 | +$12M |
| VST - Vistra | 6.89% | Add +221.7% | 257,400 | $88.45 | $23M | +177,400 | +$17M |
| AMZN - Amazon | 6.67% | Add +15.2% | 114,005 | $193.25 | $22M | +15,000 | +$4M |
| CEG - Constellation Energy | 6.09% | Add +570.0% | 100,500 | $200.27 | $20M | +85,500 | +$17M |
| DELL - Dell Technologies · CL C | 6.03% | Add +381.3% | 144,404 | $137.91 | $20M | +114,404 | +$16M |
| MSFT - Microsoft | 5.18% | Add +18.6% | 38,265 | $446.95 | $17M | +6,000 | +$4M |
| META - Meta Platforms | 4.39% | Hold | 28,742 | $504.22 | $14M | — | — |
| CRS - Carpenter Technology | 2.97% | New | 89,519 | $109.58 | $10M | +89,519 | +$10M |
| FOUR - Shift4 Payments · CL A | 2.60% | Reduce −14.6% | 116,883 | $73.35 | $9M | −20,000 | −$470K |
| DYN - Dyne Therapeutics | 2.47% | Add +696.2% | 230,900 | $35.29 | $8M | +201,900 | +$7M |
| LLY - Eli Lilly and | 2.19% | Add +23.1% | 8,000 | $905.38 | $7M | +1,500 | +$2M |
| ASML — | 2.04% | New | 6,600 | $1,023 | $7M | +6,600 | +$7M |
| DDOG - Datadog · CL A | 1.95% | Add +135.8% | 49,752 | $129.69 | $6M | +28,652 | +$4M |
| WDC - Western Digital | 1.84% | New | 80,000 | $75.77 | $6M | +80,000 | +$6M |
| NOW - ServiceNow | 1.82% | Hold | 7,622 | $786.67 | $6M | — | — |
| DHR - Danaher | 1.63% | Hold | 21,600 | $249.85 | $5M | — | — |
| JBI - Janus International Group | 1.57% | Reduce −1.0% | 362,354 | $14.33 | $5M | −3,714 | −$346K |
| ARM — | 1.34% | Add +171.0% | 27,099 | $163.62 | $4M | +17,099 | +$3M |
| Janux Therapeutics | 1.34% | Add +428.8% | 105,757 | $41.89 | $4M | +85,757 | +$4M |
| FSLR - First Solar | 1.19% | New | 15,000 | $261.33 | $4M | +15,000 | +$4M |
| TMO - Thermo Fisher Scientific | 1.18% | Hold | 7,050 | $553.00 | $4M | — | — |
| IQV - IQVIA | 1.14% | Hold | 17,742 | $211.44 | $4M | — | — |
| BLCO - Bausch Lomb | 0.97% | Add +82.3% | 221,471 | $14.52 | $3M | +100,000 | +$1M |
| AMD - Advanced Micro Devices | 0.92% | Add +108.3% | 20,000 | $152.39 | $3M | +10,400 | +$1M |
| Holding | 0.62% | Hold | 400,000 | $5.13 | $2M | — | — |
| TTWO - Take-Two Interactive Software | 0.47% | Hold | 9,945 | $155.49 | $2M | — | — |
| MDB - Mongodb · CL A | 0.43% | Reduce −21.0% | 5,632 | $249.96 | $1M | −1,500 | −$1M |
| MRVL - Marvell Technology Group | 0.42% | Reduce −78.0% | 20,000 | $69.90 | $1M | −71,050 | −$5M |
| MA - MasterCard | 0.41% | Hold | 3,100 | $441.16 | $1M | — | — |
| Freddie Mac | 0.22% | Hold | 150,000 | $4.80 | $720K | — | — |
| RTX - Raytheon | 0.15% | Hold | 5,000 | $100.39 | $502K | — | — |
| KEYS - Keysight Technologies | 0.15% | Hold | 3,650 | $136.75 | $499K | — | — |
| HDB - HDFC Bank | 0.13% | Hold | 6,500 | $64.33 | $418K | — | — |
| SOLV - Solventum | 0.08% | New | 4,800 | $52.88 | $254K | +4,800 | +$254K |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| AVGO - Broadcom | 2.11% | Exit | 0 | $1,325 | $4M | −3,000 | −$4M |
| NVO - Novo Nordisk A/S | 1.53% | Exit | 0 | $128.39 | $3M | −22,400 | −$3M |
| YPF - Ypf SA | 1.16% | Exit | 0 | $19.80 | $2M | −110,000 | −$2M |
| Terran Orbital · CL A | 0.77% | Exit | 0 | $1.31 | $1M | −1,106,704 | −$1M |
| OCUL - Ocular Therapeutix | 0.56% | Exit | 0 | $9.10 | $1M | −115,000 | −$1M |
| ORIC - Oric Pharmaceuticals | 0.29% | Exit | 0 | $13.75 | $550K | −40,000 | −$550K |
| Grupo Financiero Galicia SA | 0.27% | Exit | 0 | $25.41 | $514K | −20,230 | −$514K |
| ABCL - Abcellera Biologics | 0.11% | Exit | 0 | $4.53 | $214K | −47,265 | −$214K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 48 | $310M | +15.2% | 13F-HR | 8/18/2026 | 000156688726000004 |
| 2026 Q1 | 37 | $269M | −26.1% | 13F-HR | 5/14/2026 | 000156688726000003 |
| 2025 Q4 | 39 | $364M | +96.8% | 13F-HR | 2/12/2026 | 000156688726000002 |
| 2025 Q3 | 30 | $185M | −15.1% | 13F-HR | 11/14/2025 | 000156688725000008 |
| 2025 Q2 | 32 | $218M | −29.7% | 13F-HR | 8/14/2025 | 000156688725000005 |
| 2025 Q1 | 32 | $310M | −52.5% | 13F-HR | 5/14/2025 | 000156688725000004 |
| 2024 Q4 | 39 | $652M | +75.7% | 13F-HR | 2/14/2025 | 000156688725000003 |
| 2024 Q3 | 35 | $371M | +12.4% | 13F-HR | 11/14/2024 | 000156688724000008 |
| 2024 Q2 | 37 | $330M | +75.5% | 13F-HR | 8/14/2024 | 000156688724000007 |
| 2024 Q1 | 39 | $188M | +22.9% | 13F-HR | 5/14/2024 | 000156688724000006 |
| 2023 Q4 | 42 | $153M | +15.9% | 13F-HR | 2/14/2024 | 000156688724000004 |
| 2023 Q3 | 32 | $132M | +83.3% | 13F-HR | 11/14/2023 | 000156688723000008 |
| 2023 Q2 | 30 | $72M | +89.5% | 13F-HR | 8/15/2023 | 000156688723000006 |
| 2023 Q1 | 22 | $38M | −73.6% | 13F-HR | 5/15/2023 | 000156688723000004 |
| 2022 Q4 | 29 | $144M | +242.9% | 13F-HR | 2/14/2023 | 000156688723000002 |
| 2022 Q3 | 23 | $42M | −64.7% | 13F-HR | 11/15/2022 | 000156688722000008 |
| 2022 Q2 | 32 | $119M | −17.4% | 13F-HR | 8/16/2022 | 000156688722000006 |
| 2022 Q1 | 40 | $144M | −78.0% | 13F-HR | 5/16/2022 | 000156688722000004 |
| 2021 Q4 | 78 | $655M | −15.4% | 13F-HR | 2/14/2022 | 000156688722000002 |
| 2021 Q3 | 155 | $774M | — | 13F-HR | 11/15/2021 | 000156688721000011 |
About
Ratan Capital Management LP
20 processed 13Fs on this site · 2021 Q3–2026 Q2